Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Shanghai Shangyao First Biochemical Pharmaceutical Co., Ltd., a subsidiary of the company, received a “Drug Registration Certificate” issued by the State Drug Administration for cloverdipine emulsion injections, and the drug was approved for production. This drug is mainly used to treat high blood pressure that is not suitable for oral administration or where oral medications are not expected to be effective.

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Shanghai Shangyao First Biochemical Pharmaceutical Co., Ltd., a subsidiary of the company, received a “Drug Registration Certificate” issued by the State Drug Administration for cloverdipine emulsion injections, and the drug was approved for production. This drug is mainly used to treat high blood pressure that is not suitable for oral administration or where oral medications are not expected to be effective.